First Appendectomy Using Revolve Surgical Robotic Arm (NCT07455487) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
First Appendectomy Using Revolve Surgical Robotic Arm
3 participantsStarted 2026-04-01
Plain-language summary
This study is testing a new surgical device called the Revolve Surgical System (RSS) during appendix removal surgery. The RSS is designed to help surgeons perform minimally invasive surgery with improved precision and stability while working at the patient's bedside, similar to standard laparoscopic surgery but with robotic assistance.
This will be the first time the device is used in patients. It will be evaluated in three adults with uncomplicated appendicitis who are already scheduled to have an appendectomy. The purpose of the study is to assess whether the device can be used safely and effectively and to better understand how it performs during surgery.
Who can participate
Age range
21 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Inpatients at Unity Health Toronto - St. Michael's Hospital scheduled for an elective appendectomy
* Ages of 21-40 years old
* Male and non-pregnant female patients (pregnancy test required)
* No co-morbidities
* Body Mass Index (BMI) between 18.5 and 25kg/m2
* On no medications
* Not taking any recreational drugs
* Uncomplicated acute appendicitis (confirmed through abdominal ultrasound or abdominal computed tomography (CT) scan)
* The pre-operative white blood cell count (WBC) must be between 4,500 - 15,000 cells per microliter.
Exclusion Criteria:
* Any patient who does not have all the inclusion criteria described above.
* Imaging of perforated appendix, free air, phlegmon, abscess, fluid collection, other any abdominal disease.
* Any other abnormal laboratory test performed pre-operatively will cause the exclusion of the patient from the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Successful Completion of Appendectomy Using RSS Without Conversion
Timeframe: Intraoperative (from skin incision to completion of surgery)